Impact BioMedical effects 1-for-12 reverse stock split, cuts shares outstanding to about 8.6 million

• Impact BioMedical effected a 1-for-12.62 reverse stock split, following board action in November 2025 and stockholder authorization in December 2025.
• The split took effect Sept. 23, 2026 at 12:01 a.m. EST; trading shifted to split-adjusted basis that day under IBO.
• Shares outstanding fell to about 8,600,000 from about 107,800,000; authorized share counts, par value, voting rights remained unchanged.
• Holders received full shares in lieu of fractional entitlements; positions held in book-entry or via brokers adjusted automatically.
• Company filed the Nevada charter amendment Sept. 23; a clerical processing error delayed the file-stamped copy until Oct. 6.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Impact Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-046572), on October 09, 2026, and is solely responsible for the information contained therein.